While Ozempic’s weight loss benefits are widely touted, the conversation is increasingly shifting toward its side effects. Commonly reported issues include: nausea, constipation and “Ozempic face,” a condition where rapid weight loss leads to a gaunt appearance.

According to a report, Ozempic is not approved for weight loss, but some physicians prescribe it to be used for weight loss. “Ozempic® is not FDA approved for weight loss or chronic weight management,” the Ozempic website says.

FDA approval: Ozempic is FDA-approved for Type 2 diabetes, while Wegovy is FDA-approved for weight loss. Cost: Ozempic is typically more affordable than Wegovy. At the time of publishing, the list price for Ozempic was $968.52 per month, whereas the list price for Wegovy was $1,349.02 per month. List prices are the price set by the manufacturer.